Selçuk University is state-owned higher educational institution, which was founded 1975 in Konya, Turkey.

During the past decade, Selcuk University Medical Faculty conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 3 clinical trials were completed, i.e. on average, 10.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 3 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Selcuk University Medical Faculty" #1 sponsor was "Selcuk University" with 12 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Abbott Nutrition" with 2 trials sponsored, "Diskapi Teaching and Research Hospital" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Selcuk University Medical Faculty" #1 collaborator was "The Scientific and Technological Research Council of Turkey" with 3 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Selcuk University Medical Faculty" are "Urolithiasis" (3 trials), "Blood Transfusion" (2 trials), "Carpal Tunnel Syndrome" (2 trials), "Kidney Stones" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Selcuk University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Selcuk University Medical Faculty" are "Drug" (10 trials), "Other" (7 trials), "Device" (5 trials), "Procedure" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Placebo" (4 trials), "Blood transfusion" (2 trials), "Endoscopic kidney stone surgery" (2 trials) and "Fenebrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Selcuk University Medical Faculty" are 28 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Selcuk University Medical Faculty". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Selcuk University Medical Faculty, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Selcuk University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".